NFKB1 and neoplasm: In line with this, recent research has shown that tumor cells induce Irg1 expression in macrophages by activating the NF-κB pathway, and the resulting ITAs inhibit the expression of inflammatory genes and the infiltration of CD8+T cells into tumor sites [114].